Use of recombinant human granulocyte-macrophage colony stimulating factor in an infant with reticular dysgenesis.
We present the case of a 2-month-old infant with reticular dysgenesis who was treated with recombinant granulocyte-macrophage colony stimulating factor with the aim of stimulating granulopoiesis while awaiting bone marrow transplant.